文献速递美容整形

面部美容手术后使用美容面部注射剂的情况

Use of Cosmetic Facial Injectables After Facial Aesthetic Surgery.
PubMed 文献 · Aesthet Surg J · 2022-01-01

回顾性分析2013至2021年单术者158例面部美容手术患者,术后注射剂使用率44.3%(73例)高于术前17.7%(28例)(P < 0.001),最常见为神经毒素(48.5%)和面部填充剂(46.0%)。多因素回归显示,索引眼睑成形术或鼻成形术及术前神经毒素注射史与未来注射剂使用正相关(P < 0.05)。

要点

  • 术后注射剂使用率44.3%(73例)高于术前17.7%(28例),差异有统计学意义(P < 0.001)。
  • 术后最常用注射剂为神经毒素(48.5%)和面部填充剂(46.0%)。
  • 索引眼睑成形术或鼻成形术及术前神经毒素注射史与未来注射剂使用正相关(P < 0.05)。

核心结论

  • 美容面部注射剂是实现和维持最佳面部美学的重要考量,术后使用尤其神经毒素和面部填充剂有所增加。
  • 结果凸显注射剂操作在多维面部美学增强诊疗中的贡献。

研究设计与样本

  • 回顾性综述2013至2021年间由单一术者手术的所有成年患者。
  • 纳入接受除皱术、眼睑成形术、鼻成形术或颏成形术的患者,共审查227例,最终纳入158例。

主要发现

  • 纳入患者中,除皱术89例(56.3%)、眼睑成形术112例(70.9%)、鼻成形术28例(17.7%)、颏成形术7例(4.4%)。
  • 术后接受注射剂者占44.3%(73例),术前仅17.7%(28例)(P < 0.001)。
  • 术后最常用注射剂为神经毒素(48.5%)和面部填充剂(46.0%),脱氧胆酸(2.7%)和聚左旋乳酸(2.7%)次之。
  • 多因素回归显示,与未来注射剂使用正相关的因素为索引眼睑成形术或鼻成形术及术前神经毒素注射史(P < 0.05)。

关键数值与推荐

  • 术后注射剂使用率44.3%(73例)vs 术前17.7%(28例)(P < 0.001)。
  • 术后神经毒素使用率48.5%,面部填充剂46.0%,脱氧胆酸2.7%,聚左旋乳酸2.7%。
  • 与未来注射剂使用正相关的因素:索引眼睑成形术或鼻成形术、术前神经毒素注射史(P < 0.05)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Over the last 2 decades, both invasive and minimally invasive aesthetic procedures have proliferated. Aesthetic surgeons often recommend injectable treatments after cosmetic facial surgery for multiple reasons. However, literature is lacking on how cosmetic surgery affects postoperative facial injectable use. OBJECTIVES: The aim of this study was to identify predictors of facial injectable use after cosmetic facial surgery. METHODS: All adult patients operated on by a single surgeon between 2013 and 2021 were retrospectively reviewed. Patients who had any of the following cosmetic facial surgeries were included: rhytidectomy, blepharoplasty, rhinoplasty, or genioplasty. Patient demographics, clinical history, intraoperative factors, and use of cosmetic facial injectables (neurotoxin, facial fillers, deoxycholic acid, poly-l-lactic acid) were recorded. RESULTS: A total of 227 patients who underwent facial cosmetic surgery were reviewed, of whom 158 were included. Of these, 89 patients had rhytidectomy (56.3%), 112 had blepharoplasty (70.9%), 28 had rhinoplasty (17.7%), and 7 had genioplasty (4.4%). Injectables were administered to 44.3% of patients after their surgery (n = 73), compared with only 17.7% before surgery (n = 28) (P < 0.001). The most common postoperative injectables were neurotoxins (48.5%) and facial fillers (46.0%), followed by deoxycholic acid (2.7%) and poly-l-lactic acid (2.7%). Multivariate regression revealed factors positively correlated with future injectable use were index blepharoplasty or rhinoplasty, and history of preoperative neurotoxin injection (P < 0.05). CONCLUSIONS: Cosmetic facial injectables are an important consideration in achieving and maintaining optimal facial aesthetics. Their use, especially neurotoxins and facial fillers, has increased among patients postoperatively. These results highlight the contribution of injectable procedures in the context of multidimensional care for augmenting facial aesthetics.

来源:Aesthet Surg J,查看原文。版权归原作者所有。

引用

  1. Talwar AA, Shulkin JM, Hitchner M, et al. Use of Cosmetic Facial Injectables After Facial Aesthetic Surgery. Aesthet Surg J. 2022. PMID: 35764098. doi:10.1093/asj/sjac171

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。